Notice of Change to Application Due Dates for PAR-21-341, Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
Notice Number:
NOT-CA-23-024

Key Dates

Release Date:

December 14, 2022

Related Announcements

PAR-21-341 - Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

Issued by

National Cancer Institute (NCI)

Purpose

This Notice of Change impacts the AIDS Application Due Dates for PAR-21-341, Exploratory Grants in Cancer Control (R21 Clinical Trial Optional).

Part 1. Overview Information, Key Dates

Currently reads:

Application Due Dates

Review and Award Cycles

New

Renewal / Resubmission / Revision (as allowed)

AIDS

Scientific Merit Review

Advisory Council Review

Earliest Start Date

June 07, 2022

June 07, 2022

June 07, 2022

November 2022

January 2023

March 2023

October 07, 2022

October 07, 2022

October 07, 2022

March 2023

May 2023

July 2023

June 07, 2023

June 07, 2023

June 07, 2023

November 2023

January 2024

March 2024

October 09, 2023

October 09, 2023

October 09, 2023

March 2024

May 2024

July 2024

June 07, 2024

June 07, 2024

June 07, 2024

November 2024

January 2025

March 2025

October 08, 2024

October 08, 2024

October 08, 2024

March 2025

May 2025

July 2025

Expiration Date: October 09, 2024

Revised to read (in bold italics):

Application Due Dates

Review and Award Cycles

New

Renewal / Resubmission / Revision (as allowed)

AIDS

Scientific Merit Review

Advisory Council Review

Earliest Start Date

June 07, 2022

June 07, 2022

June 07, 2022

November 2022

January 2023

March 2023

October 07, 2022

October 07, 2022

October 07, 2022

March 2023

May 2023

July 2023

June 07, 2023

June 07, 2023

June 07, 2023

November 2023

January 2024

March 2024

October 09, 2023

October 09, 2023

November 09, 2023

March 2024

May 2024

July 2024

June 07, 2024

June 07, 2024

June 07, 2024

November 2024

January 2025

March 2025

October 08, 2024

October 08, 2024

November 08, 2024

March 2025

May 2025

July 2025

Expiration Date: November 09, 2024

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Mukesh Verma, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6889
Email: vermam@mail.nih.gov

Peer Review Contact(s)

Examine your eRA Commons account for review assignment and contact information (information appears two weeks after the submission due date).

Financial/Grants Management Contact(s)

Dawn Mitchum
National Cancer Institute (NCI)
Telephone: 240-276-5699
Email: dawn.mitchum@nih.gov